Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients
Clinical trial NCT00221624 · COMPLETED
Trial details
- NCT number
- NCT00221624
- Sponsor
- University Hospital, Bordeaux
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-11-01
- Enrollment
- 131
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.